Jim Simons

ImmunityBio Inc (NASDAQ:IBRX) has already delivered one of 2026's most explosive stock moves. But the conditions behind its 471% year-to-date surge suggest the most volatile phase may still lie ahead. Source: Benzinga IBRX stock surged nearly 86% in the past month alone, driven by regulatory...

GameStop Corp (NYSE:GME) has spent 2025 in a prolonged slide — down 25% over the past year, and more than 30% in the last six months as post-meme-era reality sank in. Yet in true GME fashion, the past five days have delivered a plot twist: the stock has popped nearly 5% — and the spark came from...

Hims & Hers Health Inc. (NYSE:HIMS) has become one of 2025's most surprising winners, up more than 150% year-to-date and over 200% in the past twelve months. But what's making Wall Street sit up this time is not another flashy partnership — it's a rally built from within. Track HIMS stock here...

Intel Corp's (NASDAQ: INTC) stock has been a rollercoaster, but four hedge fund titans — David Tepper, Ken Griffin, Jim Simons and Cliff Asness — are laughing to the bank with almost $290 million in gains since June. As INTC rockets 39.38% from $22.40 to $31.22, is this billionaire quartet's bet...

Donald Trump's relationship with Intel Corp (NASDAQ:INTC) has flipped almost overnight. After calling the chipmaker "a disaster" last year, the president is now touting it as a national champion — right as the stock begins to claw its way back. Track INTC stock’s trajectory here. Trump's...

Jim Simons, a mathematician turned investor with remarkable success, once mentioned to a group of students that the only rule he’s stood by while investing is not letting gut instinct interfere with his math. What Happened: In a newly resurfaced 2014 talk at San Francisco State...

Late investor Jim Simons‘ fund Renaissance Technologies LLC made some significant changes within its artificial intelligence bets during the fourth quarter of 2024. The 13F SEC filings reveal that Renaissance increased its stake in a few Asia-based AI companies during the quarter. What...

Palantir Technologies Inc. (NYSE:PLTR) stock continues to ride high, but hedge fund titans are easing off the throttle. Hedge Funds Take Profits, Not Exit Palantir’s stock has captured market attention with its meteoric rise to a 52-week high of $66.07, but hedge funds are stepping back—...

Editor’s Note: The headline has been revised for clarity. Renaissance Technologies, the hedge fund founded by legendary mathematician and former National Security Agency code breaker Jim Simons, recently disclosed its latest stock holdings in a 13F filing with the U.S. Securities and Exchange...

Jim Simons, RIP When news of Jim Simons' passing broke on Friday, may noted the extraordinary returns of his firm's flagship fund.  IF YOU INVESTED JUST $1,000 IN JIM SIMONS MEDALLION FUND IN 1988 YOU WOULD HAVE OVER $42 MILLION DOLLARS TODAY FOR COMPARISON IF YOU BOUGHT THE S&P...

Jim Simons, a titan in the world of finance, mathematics and philanthropy, died in New York City on Friday. He was 86. Born James Harris Simons on April 25, 1938, in Newton, Massachusetts, he showed early promise in mathematics. He attended the Massachusetts Institute of Technology, earning his...

Jim Simons is a multifaceted American who has achieved remarkable success in multiple fields. A mathematician by training, he later turned his talents towards finance, founding Renaissance Technologies, a highly quantitative hedge fund. Through his work there, Simons has garnered a reputation as...